Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne by Martin Lane and Steve Jones September 4, 2023April 30, 2024 Avecho Biotechnology saw revenue from ordinary activities fall 41% to A$446k in the half year to […]
Company news: Rua Bioscience; IDT Australia; Emyria; Elixinol Wellness; Neurotech; Hygrovest; Releaf Group/ICCM; Botanix by Martin Lane August 30, 2023April 30, 2024
Company news: Elixinol/The Sustainable Nutrition Group; Emyria by Steve Jones August 8, 2023April 30, 2024
Financial results: Bod Science; Zelira Therapeutics; Emyria; Epsilon Healthcare; Elixinol; MGC Pharma by Steve Jones August 1, 2023April 30, 2024
Emyria shares take a hit as company raises another A$2.5 million by Steve Jones May 1, 2023April 30, 2024
Emyria eyes US market with launch of high-dose CBD capsule by Steve Jones April 24, 2023April 30, 2024
Company news: Health House; Little Green Pharma; Incannex; Emyria by Steve Jones and Martin Lane April 19, 2023April 30, 2024
Emyria strikes commercial deal with Aspen for over-the-counter product by Steve Jones April 4, 2023April 30, 2024
Company news: Neurotech; Emyria; InhaleRx by Martin Lane and Steve Jones March 23, 2023April 30, 2024
Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira by Martin Lane and Steve Jones March 1, 2023April 30, 2024
